Amgen stock has been underperforming the broader market over the past year, and analysts are adopting a cautiously bullish ...

Over the past year, many Amgen Inc. ( NASDAQ:AMGN ) insiders sold a significant stake in the company which may ...

In the current session, Amgen Inc. (NASDAQ: AMGN) is trading at $291.80, after a 0.07% drop. Over the past month, the stock fell by 2.04%, and in the past year, by 7.92%. With performance like this, ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

Marjorie Taylor Greene discloses buying more stocks in October. Here's a look at what she added to her portfolio.

Denny’s board unanimously approved the deal, which values Denny’s at $620 million including debt. Denny’s will be purchased ...

Amgen’s (AMGN) earnings are expected to decline in the third quarter, which is scheduled for November 4, after markets close.

Beyond the corporate results, market participants will also be monitoring several important economic data releases, including the job openings figures, manufacturing and services PMIs, figures for TBA ...

Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the fourth ...

iShares Biotechnology ETF (IBB) offers targeted exposure to the U.S. biotechnology sector, providing investors with access to ...

suggests a Moderate Buy analyst consensus rating for Amgen with a $323.38 average price target, implying a 10.8% upside from current levels. In a report issued on October 24, Oppenheimer also ...

Coming up: earnings from AMD, Palantir, top pharmaceutical and tech firms; private-sector employment report; consumer sentiment.